New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins - PubMed (original) (raw)
New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins
J Ko et al. Brain Res Bull. 2001 Oct-Nov.
Abstract
We produced eight anti-huntingtin (Htt) monoclonal antibodies (mAbs), several of which have novel binding patterns. Peptide array epitope mapping shows that mAbs MW1-6 specifically bind the polyQ domain of Htt exon 1. On Western blots of extracts from mutant Htt knock-in mouse brain and Huntington's disease lymphoblastoma cell lines, MW1-5 all strongly prefer to bind to the expanded polyQ repeat form of Htt, displaying no detectable binding to normal Htt. These results suggest that the polyQ domain can assume different conformations that are distinguishable by mAbs. This idea is supported by immunohistochemistry with wild type (WT) and mutant Htt transgenic mouse (R6) brains. Despite sharing the same epitope and binding preferences on Western blots, MW1-5 display distinct staining patterns. MW1 shows punctate cytoplasmic and neuropil staining, while MW2-5 strongly stain the neuronal Golgi complex. MW6, in contrast, stains neuronal somas and neuropil. In addition, despite their preference for mutant Htt on blots, none of these mAbs show enhanced staining of R6 brains over WT, and show no binding of the Htt-containing nuclear inclusions in R6 brains. This suggests that in its various subcellular locations, the polyQ domain of Htt either takes on different conformations and/or is differentially occluded by Htt binding proteins. In contrast to MW1-6, MW7, and 8 can differentiate transgenic from WT mice by staining nuclear inclusions in R6/2 brain; MW8 displays no detectable staining in WT brain and stains only inclusions in R6/2 brain. Epitope mapping reveals that MW7 and 8 specifically bind the polyP domains and amino acids 83-90, respectively. As with MW1-6, the epitopes for MW7 and 8 are differentially available in the various subcellular compartments where Htt is found.
Similar articles
- Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity.
Khoshnan A, Ko J, Patterson PH. Khoshnan A, et al. Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):1002-7. doi: 10.1073/pnas.022631799. Epub 2002 Jan 15. Proc Natl Acad Sci U S A. 2002. PMID: 11792860 Free PMC article. - Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment.
Legleiter J, Lotz GP, Miller J, Ko J, Ng C, Williams GL, Finkbeiner S, Patterson PH, Muchowski PJ. Legleiter J, et al. J Biol Chem. 2009 Aug 7;284(32):21647-58. doi: 10.1074/jbc.M109.016923. Epub 2009 Jun 2. J Biol Chem. 2009. PMID: 19491400 Free PMC article. - Anti-PolyQ Antibodies Recognize a Short PolyQ Stretch in Both Normal and Mutant Huntingtin Exon 1.
Owens GE, New DM, West AP Jr, Bjorkman PJ. Owens GE, et al. J Mol Biol. 2015 Jul 31;427(15):2507-2519. doi: 10.1016/j.jmb.2015.05.023. Epub 2015 Jun 3. J Mol Biol. 2015. PMID: 26047735 Free PMC article. - Toward cell specificity in SCA1.
Humbert S, Saudou F. Humbert S, et al. Neuron. 2002 May 30;34(5):669-70. doi: 10.1016/s0896-6273(02)00715-8. Neuron. 2002. PMID: 12062012 Review. - Transgenic models of Huntington's disease.
Sathasivam K, Hobbs C, Mangiarini L, Mahal A, Turmaine M, Doherty P, Davies SW, Bates GP. Sathasivam K, et al. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):963-9. doi: 10.1098/rstb.1999.0447. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434294 Free PMC article. Review.
Cited by
- Fragment-based drug discovery for disorders of the central nervous system: designing better drugs piece by piece.
Chan BWGL, Lynch NB, Tran W, Joyce JM, Savage GP, Meutermans W, Montgomery AP, Kassiou M. Chan BWGL, et al. Front Chem. 2024 Apr 18;12:1379518. doi: 10.3389/fchem.2024.1379518. eCollection 2024. Front Chem. 2024. PMID: 38698940 Free PMC article. Review. - Early whole-body mutant huntingtin lowering averts changes in proteins and lipids important for synapse function and white matter maintenance in the LacQ140 mouse model.
Shing K, Sapp E, Boudi A, Liu S, Seeley C, Marchionini D, DiFiglia M, Kegel-Gleason KB. Shing K, et al. Neurobiol Dis. 2023 Oct 15;187:106313. doi: 10.1016/j.nbd.2023.106313. Epub 2023 Sep 28. Neurobiol Dis. 2023. PMID: 37777020 Free PMC article. - Toxic effects of mutant huntingtin in axons are mediated by its proline-rich domain.
Brady ST, Mesnard-Hoaglin NA, Mays S, Priego M, Dziechciowska J, Morris S, Kang M, Tsai MY, Purks JL, Klein A, Gaona A, Melloni A, Connors T, Hyman B, Song Y, Morfini GA. Brady ST, et al. Brain. 2024 Jun 3;147(6):2098-2113. doi: 10.1093/brain/awad280. Brain. 2024. PMID: 37633260 Free PMC article. - Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapies.
Vauleon S, Schutz K, Massonnet B, Gruben N, Manchester M, Buehler A, Schick E, Boak L, Hawellek DJ. Vauleon S, et al. Sci Rep. 2023 Apr 1;13(1):5332. doi: 10.1038/s41598-023-32630-4. Sci Rep. 2023. PMID: 37005488 Free PMC article. - Early detection of exon 1 huntingtin aggregation in zQ175 brains by molecular and histological approaches.
Smith EJ, Sathasivam K, Landles C, Osborne GF, Mason MA, Gomez-Paredes C, Taxy BA, Milton RE, Ast A, Schindler F, Zhang C, Duan W, Wanker EE, Bates GP. Smith EJ, et al. Brain Commun. 2023 Jan 20;5(1):fcad010. doi: 10.1093/braincomms/fcad010. eCollection 2023. Brain Commun. 2023. PMID: 36756307 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous